Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02950974Completed
Randomised trial of sterofundin in hypovolemia (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: Change in serum chloride at 4 hours. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02950974.